Human leukemia cell line K562 responds to erythroid-potentiating activity

Area of Science:

• Hematology
• Cell Biology
• Molecular Biology

Background:

• Erythroid-potentiating activity (EPA) is known to stimulate normal human erythroid precursor proliferation in vitro.
• Erythroleukemia cell lines offer a model for studying regulators of erythropoiesis.

Purpose of the Study:

• To investigate the effect of erythroid-potentiating activity (EPA) on the growth of human K562 erythroleukemia cells and Friend mouse erythroleukemia cells.
• To confirm that the growth-promoting factor for erythroleukemia cells is indeed EPA.

Main Methods:

• Utilized EPA produced by a human T-lymphoblast line (Mo) for detailed studies.
• Employed gel exclusion chromatography, isoelectric focusing, and ion exchange chromatography to cofractionate EPA and the erythroleukemia growth factor.
• Compared the heat inactivation kinetics of EPA and the growth-promoting activity.

Main Results:

• Erythroid-potentiating activity (EPA) demonstrated a growth-promoting effect on both human K562 and Friend mouse erythroleukemia cells.
• The erythroleukemia growth factor cofractionated with EPA and exhibited similar heat inactivation kinetics, suggesting they are the same molecule.
• Granulocyte-macrophage colony-stimulating factor from Mo cells did not affect erythroleukemia cell growth.
• Other EPA sources, including conditioned media and urine from anemic patients, also stimulated erythroleukemia cell growth.
• Mouse EPA (burst-promoting activity) stimulated mouse but not human erythroleukemia cells.

Conclusions:

• The factor stimulating erythroleukemia cell growth is identified as erythroid-potentiating activity (EPA).
• The availability of responsive erythroleukemia cell lines is valuable for future research into the mechanism of action of EPA in erythropoiesis.